V-TABUR Izrael - angleščina - Ministry of Health

v-tabur

vitamed pharmaceutical industries ltd - alcohol 70 %; chlorhexidine gluconate - solution - external - alcohol 70 % 70 %v/v; chlorhexidine gluconate 0.5 %w/v - chlorhexidine - chlorhexidine - disinfection of the skin, and for the cleaning of babies umbillical cords until detached.

POLYSEPT OINTMENT Izrael - angleščina - Ministry of Health

polysept ointment

rekah pharmaceutical industry ltd, israel - povidone-iodine - ointment - povidone-iodine 10 % - povidone-iodine - povidone-iodine - for the disinfection of skin infections and inflammations, wounds and superficial burns.

POLYSEPT SOLUTION Izrael - angleščina - Ministry of Health

polysept solution

rekah pharmaceutical industry ltd, israel - povidone-iodine - solution - povidone-iodine 10 % - povidone-iodine - povidone-iodine - antiseptic for use in first aid in wounds, scratches, mild burns. for treatment of skin infections caused by bacteria or fungi.

V-CRIMA Izrael - angleščina - Ministry of Health

v-crima

vitamed pharmaceutical industries ltd - hydroxyethylcellulose; povidone - solution - povidone 1.65 %; hydroxyethylcellulose 0.4 % - other ophthalmologicals - artificial tears.

CYTARABINE Irska - angleščina - HPRA (Health Products Regulatory Authority)

cytarabine

accord healthcare limited - cytarabine - solution for inj/inf - 100 mg/ml - cytarabine

Terazosin 5mg Tablets Irska - angleščina - HPRA (Health Products Regulatory Authority)

terazosin 5mg tablets

accord healthcare limited - terazosin - tablet - 5 milligram(s) - alpha-adrenoreceptor antagonists; terazosin

Terazosin 2mg Tablets Irska - angleščina - HPRA (Health Products Regulatory Authority)

terazosin 2mg tablets

accord healthcare limited - terazosin - tablet - 2 milligram(s) - alpha-adrenoreceptor antagonists; terazosin

Xalkori 200 mg hard capsules Evropska unija - angleščina - myHealthbox

xalkori 200 mg hard capsules

pfizer limited - crizotinib - hard capsules - 200 mg - carcinoma, non-small-cell lung - anti-neoplastic agents, protein kinase inhibitor - indicated for the treatment of adults with previously treated anaplastic lymphoma kinase (alk)-positive advanced non-small cell lung cancer (nsclc)